...
...
Next Story

Chandigarh consumer panel directs insurer to pay 72k medical claim

The panel also enhanced compensation for mental agony and harassment from ₹10,000 to ₹25,000 alongside litigation costs from ₹10,000 to ₹15,000.

Published on: Sep 6, 2026, 07:51:00 IST
Advertisement

Ruling that Care Health Insurance Ltd failed to establish claims of concealed medical history, the State Consumer Disputes Redressal Commission has directed the firm to pay an additional 72,532 towards an insured policyholder’s medical expenses.

Ruling that Care Health Insurance Ltd failed to establish claims of concealed medical history, the State Consumer Disputes Redressal Commission has directed the firm to pay an additional  ₹72,532 towards an insured policyholder’s medical expenses. (Getty Images/iStockphoto/ Representational image)
Ruling that Care Health Insurance Ltd failed to establish claims of concealed medical history, the State Consumer Disputes Redressal Commission has directed the firm to pay an additional ₹72,532 towards an insured policyholder’s medical expenses. (Getty Images/iStockphoto/ Representational image)

The panel also enhanced compensation for mental agony and harassment from 10,000 to 25,000 alongside litigation costs from 10,000 to 15,000. Delivered on August 20 by a bench of president justice Raj Shekhar Attri and member Preetinder Singh, the order partly allowed an appeal filed by Sudipta Bedbak against the District Consumer Commission-I’s verdict dated November 3, 2025.

The dispute arose after Bedbak’s mother, who was covered under the health policy, was admitted to Fortis Hospital, Mohali, on April 30, 2024. Following treatment, the insurer denied cashless authorisation and subsequently repudiated the claim on the grounds that her diabetes and insulin usage had been concealed when taking the policy.

Challenging the decision, the complainant produced medical records demonstrating that insulin therapy only commenced in 2023. Although the insurer cited an initial Fortis record describing the patient as a 20-year Type-2 diabetic using insulin and oral medications, the commission highlighted that the hospital subsequently corrected this entry. The bench noted that the insurer failed to provide independent medical evidence proving the corrected record was unreliable or that insulin use predated the policy. Furthermore, it could not identify any false declarations in the proposal form, rendering the repudiation unsustainable.

This additional sum will carry a 9% simple interest from May 14, 2024, until realisation. The directive to restore and continue the policy without a gap also stands, subject to premium payments. The insurer must comply within 45 days of receiving the certified order, failing which the principal amounts will attract a 12% simple interest.

 
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe